TransMedics Group, Inc.

NasdaqGM:TMDX 株式レポート

時価総額:US$4.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

TransMedics Group バランスシートの健全性

財務の健全性 基準チェック /26

TransMedics Groupの総株主資本は$159.5M 、総負債は$507.0Mで、負債比率は317.9%となります。総資産と総負債はそれぞれ$723.8Mと$564.4Mです。 TransMedics Groupの EBIT は$15.0Mで、利息カバレッジ比率-6です。現金および短期投資は$350.2Mです。

主要情報

267.4%

負債資本比率

US$507.75m

負債

インタレスト・カバレッジ・レシオ-11.9x
現金US$362.75m
エクイティUS$189.89m
負債合計US$568.68m
総資産US$758.58m

財務の健全性に関する最新情報

Recent updates

Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

Sep 18
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)

TransMedics: Take Profits While The Valuation Is Sky High

Sep 18

TransMedics: Wide Moat Player At A Lower Valuation Than Peers

Sep 10

TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

Aug 28
TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce

TransMedics: Heart And Lungs Will Drive The Next Leg Higher

Aug 19

Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts

TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy

Aug 04

TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

Aug 02
TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next

TransMedics Group Stock: Too Far, Too Fast

Jul 08

TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey

Jun 17

TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

Jun 10
TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger

TransMedics: Transportation Supporting Growth

May 21

TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)

May 06

TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 24
TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

TransMedics Group: Founder Led Company With Solid Potential

Apr 19

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 11
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway

Mar 19

TransMedics Group: Huge Opportunity In Organ Transplants

Mar 12

TransMedics: A Very Expensive Growth Stock

Feb 07

With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Jan 23
With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For

Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Jan 02
Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

Nov 05
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?

This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

Aug 06
This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year

TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

Aug 02
TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?

TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Jun 29
TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing

Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

May 06
Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Apr 27
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Apr 09
Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)

Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

Jan 16
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

財務状況分析

短期負債: TMDXの 短期資産 ( $488.3M ) が 短期負債 ( $50.2M ) を超えています。

長期負債: TMDXの短期資産 ( $488.3M ) は 長期負債 ( $514.1M ) をカバーしていません。


デット・ツー・エクイティの歴史と分析

負債レベル: TMDXの 純負債対資本比率 ( 98.3% ) は 高い と見なされます。

負債の削減: TMDXの負債対資本比率は、過去 5 年間で47.7%から267.4%に増加しました。

債務返済能力: TMDXの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 4.7% )。

インタレストカバレッジ: TMDX支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。


貸借対照表


健全な企業の発掘